MLZ.F · MediPharm Labs Corp

-

Please sign in to comment on MLZ.F

1 Comment

Admin

4 years ago

MediPharm Labs Corp is currently in a long term downtrend where the price is trading 24.5% below its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.

MediPharm Labs Corp's total revenue sank by 84.8% to $5M since the same quarter in the previous year.

Its net income has dropped by 364.7% to $-15M since the same quarter in the previous year.

Finally, its free cash flow grew by 11.8% to $-7M since the same quarter in the previous year.

Based on the above factors, MediPharm Labs Corp gets an overall score of 2/5.

Exchange	F
CurrencyCode	EUR
ISIN	CA58504D1006
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Beta	0.56
Market Cap	22M
Target Price	None
PE Ratio	None
Dividend Yield	None

ABOUT

MediPharm Labs Corp

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

MLZ.F · MediPharm Labs Corp

-

MediPharm Labs Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest MediPharm Labs Corp using a moving average strategy